Arsenite-induced apoptosis of human neuroblastoma cells requires p53 but occurs independently of c-Jun
Authors:
- O.G. RösslerORO.G. Rössler
- T.L. RothhaarTRT.L. Rothhaar
- G. ThielGTG. Thiel
- 1 March 2012
- journal article
- Published by Elsevier in Neuroscience
- Vol. 206, 25-38
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- p53 is Nuclear and Functional in Both Undifferentiated and Differentiated NeuroblastomaCell Cycle, 2007
- Hyperubiquitylation of wild-type p53 contributes to cytoplasmic sequestration in neuroblastomaCell Death & Differentiation, 2007
- MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell deathMolecular Cancer Therapeutics, 2006
- Mechanisms underlying differential expression of interleukin-8 in breast cancer cellsOncogene, 2004
- JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cellsBlood, 2004
- A System for Stable Expression of Short Interfering RNAs in Mammalian CellsScience, 2002
- Nitric oxide‐induced programmed cell death in human neuroblastoma cells is accompanied by the synthesis of Egr‐1, a zinc finger transcription factorJournal of Neuroscience Research, 2002
- Arsenic trioxide induces apoptosis in human gastric cancer cells through up‐regulation of P53 and activation of caspase‐3International Journal of Cancer, 2000
- Betulinic acid induces apoptosis through a direct effect on mitochondria in neuroectodermal tumorsMedical and Pediatric Oncology, 2000
- Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosisJournal of Cellular Physiology, 1998